Blog posts:

Shweta Kumar, Christopher Morten & Joseph J. Ross, “Promoting clinical trial transparency through the courts: A strategic lawsuit against the FDA,” TranspariMED Blog (Oct. 23, 2019). 



Letters and public comments:

Letter of Doshi et al. re: Docket No. FDA-2019-N-2012 (“New Drugs Regulatory Program Modernization: Improving Approval Package Documentation and Communication”) (August 23, 2019). 



Scientific and medical journal publications: 

Egilman, A.C.; Wallach, J.D.; Morten, C.J.; Lurie, P.; Ross, J.S. “Systematic overview of Freedom of Information Act requests to the Department of Health and Human Services from 2008 to 2017,” Research Integrity and Peer Review 2019, 4, 26.

Mousseau, J. J.; Morten, C. J.; Jamison, T. F. “A Dioxane Template for Highly Selective Epoxy Alcohol Cyclizations,” Chem. Eur. J. 2013, 19, 10004-16.

Morten, C. J.; Byers, J. A.; Jamison, T. F. “Evidence that Epoxide-Opening Cascades Promoted by Water Are Stepwise and Become Faster and More Selective After the First Cyclization,” J. Am. Chem. Soc. 2011, 133, 1902-08.

Morten, C. J.; Byers, J. A.; Van Dyke, A. R.; Vilotijevic, I.; Jamison, T. F. “The Development of Endo- Selective Epoxide-Opening Cascades in Water,” Chem. Soc. Rev. 2009, 38, 3175-92.

Morten, C. J.; Jamison, T. F. “New Strategies for the Stereocontrolled Synthesis of Substituted ʻSkippedʼ Diepoxides,” Tetrahedron 2009, 65, 6648-55.

Morten, C. J.; Jamison, T. F. “Water Overcomes Methyl Group Directing Effects in Epoxide-Opening Cascades,” J. Am. Chem. Soc. 2009, 131, 6678-79.







Mark